At the 7th Annual VISION conference this week, Digital Assets Council of Financial Professionals Founder Ric Edelman delivered groundbreaking portfolio allocation recommendations that fundamentally ...

The promise of genome editing to help understand human diseases and create new therapies is vast, but technological ...

In this study, we developed a standardized toolkit utilizing an engineered CRISPR/Cas9 system that enables customizable gene regulation in mammalian cells. The RNA-guided dCas9 protein was implemented ...

Stanford scientists used machine learning to design improved zinc fingers that target disease genes while minimizing immunogenicity risk.

Machine learning models have seeped into the fabric of our lives, from curating playlists to explaining hard concepts in a ...

This review brings out the major areas where CRISPR/Cas technology has improved tuber crops. Strategies for genetic transformation of RTCs with CRISPR/Cas9 constructs and regeneration of edited lines ...

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran 1449614535, Iran Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University ...

1 College of Veterinary Medicine, Northwest A&F University, Xianyang, China 2 China Animal Health and Epidemiology Center, Qingdao, China Clustered regularly interspaced short palindromic repeats ...

CRISPR Therapeutics is paying $25 million upfront to work on multiple siRNA targets with Sirius Tx with an early focus on the next-gen thrombotic disease asset SRSD107. That drug, Sirius’ lead ...

CRISPR Therapeutics stock is down more than 80% from the peak it reached in 2021. The first drug from CRISPR Therapeutics launched early last year, but annualized sales are still less than $60 ...